Navigating the Clinical Research Process for Mild Cognitive Impairment

Part of paid clinical trials in San Francisco, California.

Sponsor
Power Life Sciences Inc.
Study ID
NCT06207903
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Mild Cognitive Impairment

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Participation in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will admit a wide range of data on the clinical trial experience of mild cognitive impairment patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future mild cognitive impairment patients.

Key Dates

Start date
Feb 28, 2025
Status verified
Jan 2024
Primary completion
Feb 28, 2026
Completion
Feb 28, 2027

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Rate of patients who decide to enroll in a mild cognitive impairment clinical research. [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Power Life SciencesSan FranciscoCalifornia94107
Michael B Gill
https://www.withpower.com/[email protected]
415-900-4227

Find similar trials in San Francisco, CA

By research site
Power Life Sciences· San Francisco, CA

Related Studies